ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 927,62
0,44%
Dow Jones
44 424,25
-0,32%
DAX
21 394,93
-0,11%
Brent Oil
76,795
-0,51%
Bitcoin
101 525,30
-1,11%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Travere Therapeutics Inc (TVTX) Cours

Travere Therapeutics Inc

Travere Therapeutics Inc (TVTX)

NASDAQ
20,31
-0,50
(-2,40%)
Fermé 27 Janvier 10:00PM
Retardé de 15 minutes
20,31
0,02
(0,10%)
Après les heures de négociation: 12:10AM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
20,31
Prix Achat
20,32
Prix Vente
20,95
Volume échangé
1 266 673
20,26 Fourchette du Jour 21,56
5,12 Plage de 52 semaines 20,33
Cap du marché
1,585B
Clôture Veille
20,81
Ouverture
20,96
Dernière Transaction
3
@
20.33
Dernière heure de transaction
Volume financier
US$ 26 362 004
VWAP
20,812
Volume moyen (3 m)
1 299 239
Actions en circulation
78 049 928
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-14,22
Bénéfice par action (BPA)
-1,43
Chiffre d'affairess
145,24M
Bénéfice net
-111,4M

À propos de Travere Therapeutics Inc

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
travere.com
Siège social
Lewes, Delaware, USA
Fondé
-
Travere Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker TVTX. Le dernier cours de clôture d'Travere Therapeutics était de US$20,81. Au cours de la dernière année, les actions de Travere Therapeutics ont été négociées dans une fourchette de prix de US$ 5,12 à US$ 20,33.

Travere Therapeutics compte actuellement 78 049 928 actions en circulation. La capitalisation boursière d'Travere Therapeutics est de US$1,62 milliard. Travere Therapeutics a un ratio cours/bénéfice (ratio PE) de -14.22.

Flux d'options Travere Therapeutics (TVTX)

Voir le flux d'options complet

Flux global

Haussier

Prime nette

511k

Calls / Puts

150,00%

Ach. / Vent.

150,00%

OTM / ITM

400,00%

Sweeps Ratio

0,00%

TVTX Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

24 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Janvier 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

24 Janvier 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

23 Janvier 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

22 Janvier 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

22 Janvier 2025
Edgar (US Regulatory)

Form 8-K - Current report

13 Janvier 2025
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
11.779.5469255663418.5420.3118.24156571319.2598902CS
42.6615.070821529717.6520.3116.8118118818.50941734CS
122.3613.14763231217.9520.3316.588129923918.2724419CS
2610.68110.9034267919.6320.337.931152922815.35537757CS
5210.88115.3764581129.4320.335.12135523411.9858479CS
156-4.87-19.340746624325.1830.355.12122055515.31638045CS
260-4.84-19.244532803225.1533.08995.12108662916.64282583CS

TVTX - Frequently Asked Questions (FAQ)

What is the current Travere Therapeutics share price?
The current share price of Travere Therapeutics is US$ 20,31
How many Travere Therapeutics shares are in issue?
Travere Therapeutics has 78 049 928 shares in issue
What is the market cap of Travere Therapeutics?
The market capitalisation of Travere Therapeutics is USD 1,62B
What is the 1 year trading range for Travere Therapeutics share price?
Travere Therapeutics has traded in the range of US$ 5,12 to US$ 20,33 during the past year
What is the PE ratio of Travere Therapeutics?
The price to earnings ratio of Travere Therapeutics is -14,22
What is the cash to sales ratio of Travere Therapeutics?
The cash to sales ratio of Travere Therapeutics is 10,9
What is the reporting currency for Travere Therapeutics?
Travere Therapeutics reports financial results in USD
What is the latest annual turnover for Travere Therapeutics?
The latest annual turnover of Travere Therapeutics is USD 145,24M
What is the latest annual profit for Travere Therapeutics?
The latest annual profit of Travere Therapeutics is USD -111,4M
What is the registered address of Travere Therapeutics?
The registered address for Travere Therapeutics is 16192 COASTAL HWY, LEWES, DELAWARE, 19958
What is the Travere Therapeutics website address?
The website address for Travere Therapeutics is travere.com
Which industry sector does Travere Therapeutics operate in?
Travere Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
EVAXEvaxion Biotech AS
US$ 5,99
(64,56%)
55,41M
ELABPMGC Holdings Inc
US$ 3,0901
(56,07%)
76,48M
PCLAPicoCELA Inc
US$ 4,60
(49,35%)
3,75M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
GODNUGolden Star Acquisition Corporation
US$ 3,11
(-75,82%)
17,51k
GODNGolden Star Acquisition Corporation
US$ 2,93
(-65,67%)
902,76k
NXTTNext Technology Holding Inc
US$ 1,37
(-54,93%)
2,56M
SGLYSingularity Future Technology Ltd
US$ 1,625
(-38,45%)
917,77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90,11
(-38,07%)
8
ACONAclarion Inc
US$ 0,0557
(28,94%)
811,91M
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
RIMEAlgorhythm Holdings Inc
US$ 0,0357
(4,69%)
284,97M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
NVDANVIDIA Corporation
US$ 142,62
(-3,12%)
232,88M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
TVTX
Travere Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés